NxStage System One Use Continues in Haiti Six Years After Earthquake

LAWRENCE, Mass., Jan. 13, 2016 /PRNewswire/ -- To coincide with the sixth anniversary of the 2010 Haiti earthquake, NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of dialysis products, is recognizing the efforts of medical leaders and support teams in helping to save the lives of people suffering from acute kidney injury (AKI) after the devastating earthquake in Haiti.  Immediately following the disaster, Brian Remillard, M.D., Section Chief of Nephrology and Hypertension at Dartmouth-Hitchcock Medical Center (DHMC) led a coordinated effort to bring the portable NxStage® System One™ to Haiti to provide on-site dialysis therapy to injured survivors. With support from NxStage, Remillard's efforts have included emergency response following the earthquake, as well as long-term initiatives focused on improvements in renal care for patients in Haiti.

"I am committed as a doctor to providing care in the United States and in developing countries for both outpatient and acute inpatient dialysis," said Dr. Remillard. "The System One is extremely portable, easy to use and exactly what we needed to treat AKI patients we found in Haiti."

After the earthquake, Dr. Remillard partnered with Chief of Medicine Dr. Philip Cleophat at Partners in Health, a global health organization committed to improving the health of poor and marginalized people, to bring medical education and renal care to the hospital. Partners in Health worked for three years after the earthquake to build a 300-bed, state-of-the-art hospital, Hopital Universitaire de Mirebalais (HUM) with the goal of providing comprehensive medical care to residents of central Haiti, including advanced care for renal disease with the NxStage System One.  In March of last year, NxStage provided System One training and education to nurses from the hospital.

"What Dr. Remillard and his team have done over the past six years is an inspiration," said Joseph E. Turk, president of NxStage. "We are proud to have the System One playing an important role in treating patients in need in Haiti."

For more information about the System One or acute renal replacement therapy, please visit www.nxstage.com.

About the NxStage System One
The System One is used to provide a range of flexible therapy options in hospitals and dialysis centers. The NxStage System One is also the first and only truly portable hemodialysis system cleared specifically by the FDA for home hemodialysis and home nocturnal hemodialysis. Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage PureFlow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, including while they are sleeping - at home or on vacation and at a medically appropriate treatment frequency. In addition, NxStage's Nx2Me Connected Health platform collects important NxStage System One and patient information for flexible viewing, monitoring and reporting that may improve patient management and simplify alternative site care. http://www.nxstage.com/.

About NxStage Medical
NxStage Medical Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter September 30, 2015. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media contact: 
Kristen K. Sheppard, Esq.
[email protected] 
Tel: (978) 332-5923

Logo - http://photos.prnewswire.com/prnh/20150624/225341 
Logo - http://photos.prnewswire.com/prnh/20110503/MM94799LOGO

SOURCE NxStage Medical, Inc.

Related Links

http://www.nxstage.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED